Summary A total of 165 adult patients with Hodgkin's disease (HD) were questioned following treatment to examine their perceptions of actual and desired involvement and provision of information in the treatment decision-making process. Irrespective of the degree to which patients felt they had been involved in the decision-making process and of the outcome of their particular treatment, patients who felt satisfied with the adequacy of information given were significantly more likely to feel happy with their level of participation in the overall process of decision-making (P<0.001). As part of a strategy investigating patient priorities, patients were asked to rank a series of possible acute and late treatment-related morbidities. Counterintuitively, the majority of long-term survivors felt early short-term side-effects were more, or equally, as important as late morbidity with respect to influencing choice of therapy. 165/230 (72%).
) using radiotherapy and/or chemotherapy. Despite similar overall survival rates, single and combined modality treatments are associated with differing spectrums of early and late morbidity and risk of relapse necessitating salvage treatment. In general, treatments with the lowest rates of recurrence are favoured by clinicians, accepting some increase in acute and late toxicity over regimens with higher relapse rates. Assumptions are made in designing clinical trials as to which side-effects are the most important, although their significance relative to each other and to risk of relapse varies between trials.
This implies that the decision regarding the most appropriate therapy for a particular patient with early stage Hodgkin's disease should be influenced by the 'trade-off' they are willing to accept between risk of relapse and side-effects. While doctors and other health workers have knowledge of disease and side-effects, their perception of these and their relative priorities may differ from those of patients (Slevin et al., 1990) .
Factors enabling patients to enter into the decision-making process effectively include firstly, their having adequate information and secondly, their being involved in discussions regarding choice of therapy as much (or as little) as they desire. Patient involvement in the initial decision-making process may be hampered both by stress caused by the diagnosis and lack of experience of the disease and possible therapeutic options.
This study employed experienced surrogates to examine the issues of patients' desire for information and involvement in decision-making and to attempt to determine the relative importance of various side-effects of disease and treatment. Simple counts, proportions, chi-squared and analysis of variance (ANOVA) were carried out on an Apple Macintosh using Statview (Statview, 1992) .
Materials and methods

Patients treated for
Results
Information and involvement
In response to the question regarding the adequacy of information given, 80 patients (48%) felt they had not had enough information, 85 (51%) thought they had as much as they needed and no patients felt they had been given too much information. Fifty-one patients received written information about Hodgkin's disease and its treatment to take away with them and of the 113 that did not, 102 patients (90%) said they would have appreciated this.
The perceived level of patient involvement in the decisionmaking process for all patients is shown in Table I . A total of 102 patients (62%) indicated that they took no part in decision-making and that the doctor had been responsible for making all decisions on their behalf. Table II indicates that 95 patients (58%) were involved as much as they had wanted to be and the remainder were either dissatisfied with their level of involvement, could not remember or did not answer the question. Overall, patients having 'successful' and 'unsuccessful' treatment experiences (as defined previously) were equally likely to feel involved and satisfied with the decision-making process. Despite reporting that they had been adequately involved in the decision-making process, 25% of patients felt that there had been no real treatment choices available to them. Table III shows the relationship between patients' perceptions of the adequacy of information given at or around the time of diagnosis and satisfaction with the level of involvement in the decision-making process. Patients who felt that they had been given sufficient information were statistically significantly more likely to have felt satisfied with their particular level of involvement, irrespective of their perceived degree of participation (or lack thereof). Sixty-seven of 77 patients (87%) happy with the information given were satisfied with their level of involvement compared with 10 of 77 (13%) who were not (P<0.001; x2 test). Twenty-eight of 71 patients (39%) dissatisfied with the information given were happy with the degree to which they were involved and the remaining 43 (61%) were not. The 'success' or otherwise of the treatment experience did not appear to have any significant influence on this information/involvement relationship (ANOVA).
Perceptions of acute and long-term morbidity The median ranking for each early side-effect listed in the questionnaire, the percentage of patients ranking it first, second or third and the number of patients experiencing the side-effect in question are shown in Table IV . Nausea and vomiting (with a median rank of 1 out of 11 items) was the side-effect viewed by patients as being the most important cause of acute morbidity to be considered when choosing between treatments with equal chance of cure. Ninety-three per cent of 122 patients experiencing this side-effect ranked it first, second or third. Change in physical appearance caused by weight gain and/or hair loss, pain, fatigue during treatment and sore mouth or difficulty swallowing all received a median importance ranking of 3.5 or greater and were experienced by 115, 56, 120 and 82 patients respectively. Weight gain from steroids was a much more commonly reported cause for concern in changed physical appearance than alopecia. For each of these four symptoms, between 50% and 62% of patients experiencing them ranked them first, second or third in terms of their influence on choice of further treatment. Septic episodes requiring admission, though only suffered by 19 patients, were felt by these patients to be very significant with a median ranking of 2; 68% of these patients ranked serious infection in the top three positions.
Of possible late complications, development of a second cancer, relapse of Hodgkin's disease and cardiovascular complications were thought to be the most important potential problems to be considered when choosing between different therapies, although numbers of patients experiencing many of these problems were relatively small (Table V) (Brody, 1980; Schain, 1980; Degner and Aquino Russell, 1988 ). This approach assumes that patients want to be actively involved in decision-making, an assumption refuted by some authors (Sutherland et al., 1989; Fallowfield et al., 1994) .
Our data indicate that there are many patients who are satisfied with less than complete involvement, 26% of patients feeling satisfied with the doctor taking full responsibility for treatment decisions. Fifty-three patients (32%) had been involved at least partially in the decision-making process and the majority of these had been satisfied with this. It (Cassileth et al., 1980) . Nor does desire for participation necessarily mean that patients perceive real choices; 25% of our patients felt adequately involved without real choices being available. Several authors have dealt with the importance of how choices are presented (Strull et al., 1984; Richards et al., 1995) . The reported benefits of providing choice (patient satisfaction, reduced stress, increased compliance, improved recovery) (Krantz et al., 1980; Tuckett and Williams, 1984; Morris and Royle, 1988 ) must be balanced against the potentially increased anxiety associated with responsibility for decisions and regret for perceived 'wrong' decisions.
Another component of decision making is provision of information (Degner and Beaton, 1987) . Patient satisfaction with health care has been directly linked to whether expectations of information from doctors are fulfilled (Degner and Aquino Russell, 1988) . Others (Ley and Spelman, 1967; Ende et al., 1989; Fallowfield et al., 1994; Richards et al., 1995) have stressed that desire for information is not necessarily an expression of a desire to be involved in primary decisionmaking. Ende et al. (1989) showed no correlation between patients' information seeking and decision-making preferences. Sutherland et al. (1989) found that many patients actively sought information, but the majority preferred the doctor to make treatment decisions. Like others (Cassileth et al., 1980) , Sutherland et al. demonstrate a positive correlation between degree of information seeking and level of preference for participation in decision-making. Our results suggest that the importance of adequate information may be in favourably influencing the overall experience of the decision-making process rather than necessarily encouraging participation in choosing treatments.
The amount and content of information given are only one aspect. How information is given may sometimes be more important than what is actually said (Tuckett and Williams, 1984) . Some authors report that most patients asked directly express a desire for maximal information (Cassileth et al., 1980) , but suggest that too much information may increase stress, particularly at a time, e.g. soon after diagnosis, when recall and assimilation of information are especially impaired (Ley and Spelman, 1967; Blanchard et al., 1988) . The present study found that 90% of patients not receiving written information (62% of all patients) would have liked to have received written material. Although we did not specifically examine recall, these data would support the findings of others (Ley and Spelman, 1967) , that in most groups of patients that less than half the information given was later recalled. Penman et al. (1984) (Fobair et al., 1986; Newall et al., 1987; Bloom et al., 1993; Olweny et al., 1993; Zeltzer, 1993) have examined the adaption of survivors of Hodgkin's disease and stress the importance of quality survival from both psychological and physical points of view. The emphasis in this study was to investigate the relative importance of different morbidities to give guidance to the content of initial information 'packages'. Nausea and vomiting were perceived as the most problematic acute side-effects, as reported by others (Coates et al.,  1983) ). The introduction of 5HT antagonists may have some bearing on this finding, although recent studies suggest that S Turer et al 226 this remains a problem. The significance of septic episodes to those who had actually suffered them highlight the difficulty in conveying potential morbidities to people without experience of them. Symptoms assumed to be relatively minor, such as sore mouth and change in weight, loomed large in the patients' view. Similarly, energy loss was viewed as a considerable problem. Energy loss as a cause of late morbidity is rarely formally evaluated although the persistence of fatigue into the longer term has been repeatedly reported (Fobair et al. 1986; Bloom et al., 1990 Bloom et al., , 1993 (Fobair et al., 1986) . Kornblith et al. (1992) examined fertility in advanced Hodgkin's disease patients following treatment using an infertility index based on whether the patients believed they were or had been proven to be infertile or not. They found that although 53% were or believed they were infertile, this parameter was actually not a good predictor of survivors' overall psychological distress and concluded that it is in fact not a critical issue affecting long-term adjustment in Hodgkin's disease patients.
Our original hypothesis was that patients would rank risks of long-term side-effects of more importance than short-term, self-limiting and acute effects, but interestingly, patients perceived early acute side-effects as being at least as influential in determining choice of therapy as late, permanent morbidity despite the fact that almost exactly equal numbers of patients had some experience of early and late morbidity: 78% vs 75% for early and late side-effects respectively. It is a good example, however, of how difficult it can be to guess what patients' priorities are likely to be; a fact reported formally elsewhere. Zeltzer (1993) found similarly in a study of adolescent and young adult cancer survivors that acute side-effects of treatment were often the most vividly remembered and were reported as the worst aspect of having cancer. This must be acknowledged when offering increasingly intense initial therapies.
The issues raised by this study do not necessarily assist doctors in approaching the decision-making process for an individual patient. It must be acknowledged that cognitive dissonance affects patients' perception of the past; however, experienced surrogates have nonetheless given us counterintuitive insights into the experience, preferences and priorities of patients. One solution to the problems in describing priorities might be to involve survivors in the design of clinical trials, or in the initial information-giving process. This approach has proved promising in other areas (Bradburn et al., 1995) . These data suggest that although many patients do wish for maximal participation in decisionmaking, many patients would prefer the doctor to take full responsibility for choice of therapy. Desire for information was more universal and related to satisfaction with the entire decision-making process. Desire for information and desire for full participation in decision-making can not be equated.
Further, these data support the notion that doctors treating Hodgkin's disease patients and designing trials in which to enter them may not necessarily have identified the outcomes that are of significance to patients themselves. It appears that acute side-effects may be of as least as much importance to patients as risk of late morbidity, and that early and late effects not routinely examined such as energy loss or change in appearance, may be more significant to patients than others that are regularly examined. If we are going to address the issues most pertinent to patients in this and other areas of oncology then the relevant questions must be incorporated into the design of future clinical trials. The results of this study further emphasise the need for routine use of validated self-report quality of life instruments.
